These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33299325)

  • 1. Oncogenic Role of NUPR1 in Ovarian Cancer.
    Yu J; Zhu H; Li R; Jiang Q; Luan W; Shi J; Liu P
    Onco Targets Ther; 2020; 13():12289-12300. PubMed ID: 33299325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
    Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
    Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
    Miao F; Zhang X; Cao Y; Wang Y; Zhang X
    BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
    Chen L; Liu T; Zhang S; Zhou J; Wang Y; Di W
    J Ovarian Res; 2014 Dec; 7():115. PubMed ID: 25491408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
    Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
    J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines.
    Bai H; Li H; Li W; Gui T; Yang J; Cao D; Shen K
    Oncotarget; 2015 Sep; 6(28):25520-32. PubMed ID: 26267321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivirus-mediated RNAi knockdown of NUPR1 inhibits human nonsmall cell lung cancer growth in vitro and in vivo.
    Guo X; Wang W; Hu J; Feng K; Pan Y; Zhang L; Feng Y
    Anat Rec (Hoboken); 2012 Dec; 295(12):2114-21. PubMed ID: 22961798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
    Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
    Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of FXYD5 reverses the cisplatin resistance of epithelial ovarian cancer cells.
    Liu YK; Jia YJ; Liu SH; Shi HJ; Ma J
    Histol Histopathol; 2021 May; 36(5):535-545. PubMed ID: 33570156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of TROP2 promotes proliferation and invasion of ovarian cancer cells.
    Wu B; Yu C; Zhou B; Huang T; Gao L; Liu T; Yang X
    Exp Ther Med; 2017 Sep; 14(3):1947-1952. PubMed ID: 28962108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
    Wang DY; Li N; Cui YL
    Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUPR1 participates in YAP-mediate gastric cancer malignancy and drug resistance via AKT and p21 activation.
    Jiang L; Wang W; Li Z; Zhao Y; Qin Z
    J Pharm Pharmacol; 2021 Apr; 73(6):740-748. PubMed ID: 33793788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ; Chen BL; Xin XY
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing Wnt2B by siRNA interference inhibits metastasis and enhances chemotherapy sensitivity in ovarian cancer.
    Wang H; Fan L; Xia X; Rao Y; Ma Q; Yang J; Lu Y; Wang C; Ma D; Huang X
    Int J Gynecol Cancer; 2012 Jun; 22(5):755-61. PubMed ID: 22635028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis.
    Sang XB; Sun KX; Wang LL; Chen S; Wu DD; Zong ZH; Zhao Y
    Oncol Rep; 2016 Dec; 36(6):3267-3274. PubMed ID: 27748937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-allylcysteine, a garlic derivative, suppresses proliferation and induces apoptosis in human ovarian cancer cells in vitro.
    Xu YS; Feng JG; Zhang D; Zhang B; Luo M; Su D; Lin NM
    Acta Pharmacol Sin; 2014 Feb; 35(2):267-74. PubMed ID: 24362328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
    Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
    Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V
    Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role and mechanism of human trophoblastic cell surface antigen 2 in the invasion and metastasis of ovarian cancer].
    Liu MB; Shi XF; Liu K; Song WY; Wang L; Wu HY; Wu GY
    Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):299-305. PubMed ID: 33752309
    [No Abstract]   [Full Text] [Related]  

  • 20. APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target.
    Wen X; Lu R; Xie S; Zheng H; Wang H; Wang Y; Sun J; Gao X; Guo L
    Cancer Biomark; 2016 Sep; 17(3):313-322. PubMed ID: 27802207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.